Home › Trials › NCT04791098
Clinical trial No longer in our active list Interventional Ages 18 and up

Improving vaccination coverage for kidney transplant patients

Official title: Impact of Infectious Diseases Consultation on Vaccination Coverage Among People Waiting for a Kidney Transplant at the Clermont-Ferrand Hospital

Run by University Hospital, Clermont-Ferrand · NCT04791098 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is testing if special consultations can help people waiting for kidney transplants get better vaccination coverage compared to standard care.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment150 (estimated)
SponsorUniversity Hospital, Clermont-Ferrand
Academic / other
Locations1 site (Clermont-Ferrand)
Trial IDNCT04791098 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults over 18 who are on the waiting list for kidney transplantation at Clermont-Ferrand.

Probably not a fit

Patients under 18, pregnant or nursing women, and those with prior organ transplants will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to enhance vaccination coverage among patients waiting for kidney transplants by implementing a dedicated infectious diseases consultation. Patients on the transplant waiting list will be invited to participate and will undergo health assessments, including blood tests and imaging. Those in the intervention group will receive specialized consultations to address vaccination needs, while the control group will receive standard care. The effectiveness of this approach will be measured by evaluating immunization coverage six months after the intervention.

Why it matters

Potential benefit: If successful, this study could significantly improve vaccination rates and reduce the risk of infectious diseases in kidney transplant patients.

How similar studies have gone: While there is limited data on this specific approach, similar studies have shown that targeted interventions can improve vaccination rates in at-risk populations.

Who can join: the full rules

Show full inclusion / exclusion criteria 
Inclusion Criteria:

* Patient over 18
* On the waiting list for kidney transplantation at Clermont-Ferrand
* Free and informed consent
* Affiliation to a social security system

Exclusion Criteria:

* Patient under 18
* Protected adults (individuals under guardianship by court order
* Pregnant and nursing women
* Prior graft (solid organs or hematopoietic stem cells)
* Absence of consent

Where it's running

  • CHU de Clermont-Ferrand
    Clermont-Ferrand, France     Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
View on ClinicalTrials.gov ↗ Find more trials like this →
Browse more
Kidney Transplantation 104University Hospital, Clermont-Ferrand 104
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.